Skip to main content

Table 1 Data summary

From: Depression in adults with sickle cell disease: a systematic review of the methodological issues in assessing prevalence of depression

Year

Author

Methodology

Population

Measure

Results

Country

Recruitment setting

Sex (male, %)

Age (mean)

Genotype (SS, %)

Type

Name

Cut-off

N total

% depressed

1999

Wilson Schaeffer, J. J et al

USA

Outpatient

43.86

33.70

 

PA

CES-D 20

16

440

43.41

2000

Grant et al

USA

Outpatient

41.86

35.02

 

PA

CES-D 20

16

43

25.58

2003

Hasan et al

USA

Outpatient

54.00

36.00

94.00

PA

BDI-II

14

50

44.00

2005

Jenerette et al

USA

Cohort

28.00

35.00

 

PA

BDI 7

4

221

31.67

2006

Laurence et al

USA

Cohort

43.54

 

79.40

PA

CES-D 10

4

101

38.61

2007

Pells, J. et al

USA

Cohort

 

36.82

 

PA

LEMFPSCD (BDI-II)

14

67

35.82

2008

Levenson et al

USA

Cohort

38.40

34.00

70.96

PA

PHQ 9

10

232

27.59

2009

Carroll et al

USA

Inpatient

36.50

24.10

 

MRR

 

n/a

122

6.56

2009

Edwards et al

USA

Outpatient

 

36.82

 

PA

LEMFPSCD (BDI-II)

14

67

22.00

2010

Anie et al

Nigeria

Outpatient

   

PA

PISCD

n/a

253

44.27

2010

Asnani et al

Jamaica

Cohort

49.46

31.00

 

PA

BDI-II

14

277

21.66

2010

Kamble et al

USA

Outpatient

42.96

34.20

 

PA

BDI-II

14

142

35.21

2010

Mahdi et al

Bahrain

Outpatient

42.80

17.23

100

PA

DASS 21

10

243

59.26

2011

Carroll et al

USA

Inpatient

   

MRR

 

n/a

1874

4.27

2011

Treadwell et al

USA

Outpatient

 

31.20

 

PA

PHQ 9

10

77

61.04

2012

Rosine

Europe

Outpatient

44.30

35.60

100

PA

BDI-II

14

89

49.44

2012

Vilela et al

Brazil

Outpatient

32.00

35.00

100

PA

BDI-II

20

24

16.67

2013

Gibson et al

Jamaica

Outpatient

48.00

36.40

70.00

PA

BDI-II

17

143

13.29

2014

Morgan et al

Jamaica

Outpatient

 

35.97

69.60

PA

BDI-II

14

140

15.00

2014

Wallen et al

USA

Cohort

49.00

34.00

85.00

PA

BDI-II

16

315

20.63

2015

Mann-Jiles et al

USA

Outpatient

49.00

 

64.00

MRR

 

n/a

72

19.44

2015

Mastandréa et al

Brazil

Outpatient

38.20

30.00

72.70

PA

PHQ 9

10

110

30.00

2015

Treadwell et al

USA

Cohort

40.00

31.60

73.00

PA

PHQ 9

10

77

32.47

2016

Al Sherawi et al

Oman

Outpatient Inpatient

34.00

  

PA

BDI-II

14

123

39.02

2016

Anim et al

Ghana

Outpatient

51.00

 

65.00

PA

BSI

?

201

0.00

2016

Fayand et al

Europe

Inpatient

43.00

27.00

 

MRR

 

n/a

439

5.24

2016

Ola et al

Nigeria

Outpatient

38.83

25.30

98.06

PA

PHQ 9

5

103

71.84

2016

Master et al

USA

Outpatient

48.00

33.00

 

PA

PROMIS

55

100

35.00

2016

Raji et al

Nigeria

Outpatient

46.30

25.37

 

Interview

Mini

n/a

205

16.59

2017

Adam et al

USA

Outpatient

28.00

35.40

56.00

PA

BDI-II

14

142

35.21

2017

Dorociak et al

USA

Outpatient

22.20

40.61

 

PA

CES-D 20

16

54

38.89

2018

Alhomoud et al

Saudi Arabia

Outpatient

57.30

31.70

100

PA

BDI-II

14

110

48.18

2018

Alsubaie et al

Saudi Arabia

Outpatient

35.90

26.40

 

PA

HAM-D 17

8

78

85.90

2018

Ahmadi et al

Iran

Outpatient

35.10

 

64.90

PA

DASS 21

5

97

67.01

2018

Williams et al

USA

Inpatient

52.00

27.50

 

Interview

ED-Scan

n/a

95

29.47

2018

Simo et al

USA

VOC

20.00

 

80.00

PA

PHQ 9

10

10

50.00

  1. CES-D Centre for Epidemiologic Studies-Depression, BDI Beck Depression Inventory, LEMFPSCD Longitudinal Exploration of Medical and Psychosocial Factors in SCD, PHQ Patient Health Questionnaire, DASS Depression Anxiety Stress Scale, BSI Brief Symptom Inventory, Mini Mini International Neuropsychiatric Interview, PROMIS Patient-Reported Outcomes Measurement Information System, HAM-D Hamilton Depression scale
  2. (: estimated) (: SS + Sβ°) (VOC vaso-occlusive crisis, PA psychometric assessment, MRR medical record review, SI structured interview)